Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherRevenue - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Perspective Therapeutics (CATX) Other Gross PP&E Adjustments (2016 - 2026)

Perspective Therapeutics' Other Gross PP&E Adjustments history spans 16 years, with the latest figure at $97.4 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 54.69% to $97.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $97.4 million, a 54.69% increase, with the full-year FY2025 number at $79.2 million, up 39.91% from a year prior.
  • Other Gross PP&E Adjustments hit $97.4 million in Q1 2026 for Perspective Therapeutics, up from $79.2 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for CATX hit a ceiling of $97.4 million in Q1 2026 and a floor of $296000.0 in Q4 2022.
  • Historically, Other Gross PP&E Adjustments has averaged $33.8 million across 5 years, with a median of $14.3 million in 2023.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 96.6% in 2022 and later surged 1820.11% in 2024.
  • Tracing CATX's Other Gross PP&E Adjustments over 5 years: stood at $296000.0 in 2022, then surged by 896.28% to $2.9 million in 2023, then surged by 1820.11% to $56.6 million in 2024, then surged by 39.91% to $79.2 million in 2025, then rose by 22.9% to $97.4 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for CATX at $97.4 million in Q1 2026, $79.2 million in Q4 2025, and $68.0 million in Q3 2025.